2021
DOI: 10.3389/fimmu.2021.746235
|View full text |Cite
|
Sign up to set email alerts
|

Archaeosomes and Gas Vesicles as Tools for Vaccine Development

Abstract: Archaea are prokaryotic organisms that were classified as a new domain in 1990. Archaeal cellular components and metabolites have found various applications in the pharmaceutical industry. Some archaeal lipids can be used to produce archaeosomes, a new family of liposomes that exhibit high stability to temperatures, pH and oxidative conditions. Additionally, archaeosomes can be efficient antigen carriers and adjuvants promoting humoral and cellular immune responses. Some archaea produce gas vesicles, which are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 49 publications
0
9
0
Order By: Relevance
“…To our knowledge, this is the first report on the effect of halophilic archaea on the maturation of human DCs and the subsequent orientation of CD4 + T cells. However, archaeosomes, which are unique liposomes composed of specific lipid extracts from halophilic archaea, almost exclusively from Halobacterium salinarum, have been produced and assessed as vaccine vehicles against various pathogens [for a recent review see (31)]. These liposomes have been shown to induce both antibody and T cell responses to the passenger antigens, implying that halophile compounds can activate antigen-presenting cells and trigger adaptive immunity.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, this is the first report on the effect of halophilic archaea on the maturation of human DCs and the subsequent orientation of CD4 + T cells. However, archaeosomes, which are unique liposomes composed of specific lipid extracts from halophilic archaea, almost exclusively from Halobacterium salinarum, have been produced and assessed as vaccine vehicles against various pathogens [for a recent review see (31)]. These liposomes have been shown to induce both antibody and T cell responses to the passenger antigens, implying that halophile compounds can activate antigen-presenting cells and trigger adaptive immunity.…”
Section: Discussionmentioning
confidence: 99%
“…Archaea, a domain of single-celled living things morphologically similar to bacteria but genetically distinct, are also used as vaccine delivery systems, especially in the form of archaeosomes [191]. The archaeosome is a liposome-based nano-delivery system developed for gene delivery.…”
Section: Archaea Bacteria and Their By-productsmentioning
confidence: 99%
“…The lipid film is then resuspended in chloroform, methanol, and water mixture, and again evaporated under vacuum. The dried lipid film is then hydrated with an aqueous buffer to form archaeosomes . Usually, the drug or a biomolecule (e.g., protein) of interest can be either encapsulated (hydrophilic) or entrapped (hydrophobic) in the archaeosomes during their formulation or incubated with the archaeosomes after their formation .…”
Section: Archaeosomes: Preparation and Characterizationmentioning
confidence: 99%
“…The dried lipid film is then hydrated with an aqueous buffer to form archaeosomes. 2 Usually, the drug or a biomolecule (e.g., protein) of interest can be either encapsulated (hydrophilic) or entrapped (hydrophobic) in the archaeosomes during their formulation or incubated with the archaeosomes after their formation. 17 A variety of microscopic techniques such as cryo-transmission electron microscopy, scanning electron microscopy, fluorescence microscopy, and phase-contrast light microscopy are widely used to analyze the morphology of archaeosomes.…”
Section: Archaeosomes: Preparation and Characterizationmentioning
confidence: 99%
See 1 more Smart Citation